122 related articles for article (PubMed ID: 1279324)
1. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML).
Lamy T; Goasguen JE; Mordelet E; Grulois I; Dauriac C; Drenou B; Chaperon J; Fauchet R; le Prise PY
Leukemia; 1994 Nov; 8(11):1879-83. PubMed ID: 7526090
[TBL] [Abstract][Full Text] [Related]
3. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
[TBL] [Abstract][Full Text] [Related]
7. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
8. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.
Schachner J; Kantarjian H; Dalton W; McCredie K; Keating M; Freireich EJ
Leukemia; 1988 Oct; 2(10):667-71. PubMed ID: 3172842
[TBL] [Abstract][Full Text] [Related]
10. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
11. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials.
Paietta E; Neuberg D; Bennett JM; Dewald G; Rowe JM; Cassileth PA; Cripe L; Tallman MS; Wiernik PH;
Leukemia; 2003 Aug; 17(8):1544-50. PubMed ID: 12886241
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
[TBL] [Abstract][Full Text] [Related]
13. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
Ciolli S; Leoni F; Caporale R; Pascarella A; Salti F; Rossi-Ferrini P
Haematologica; 1993; 78(3):151-5. PubMed ID: 7690733
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia.
te Boekhorst PA; Löwenberg B; van Kapel J; Nooter K; Sonneveld P
Leukemia; 1995 Jun; 9(6):1025-31. PubMed ID: 7541095
[TBL] [Abstract][Full Text] [Related]
15. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
Leuk Lymphoma; 1995 May; 17(5-6):417-26. PubMed ID: 7549832
[TBL] [Abstract][Full Text] [Related]
16. [Long-term results of the UHKT-911 study of adult patients under 65 years of age with de novo acute myeloid leukemias without favorable karyotypes].
Lemez P; Vítek A; Michalová K; Zemanová Z; Lukásová M
Vnitr Lek; 2003 Mar; 49(3):174-80. PubMed ID: 12728590
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]